EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Journal of Sickle Cell Disease

ISSN 3029-0473 · Oxford University Press (OUP)

Latest articles

  1. Efficacy and safety of osivelotor in participants with sickle cell disease in a 12-week, phase 2, multicenter, open-label, dose-finding trial and extension study

    Santosh L Saraf, Shehu U Abdullahi, Adeseye M Akinsete, Foluke A Fasola, Modupe Idowu, Sharon Pennington, Sheinei S Alan, Marshall Patrick Stagg, Earl J Fields, David R Archer, Aliya Zaidi, Patrick Hines, Yuvika Paliwal, Denis Rybin, Eric I Zimmerman, Adeyemi Adenola, Mira Patel Pochron, Eleanor A Lisbon, Geoffrey Allen

    Published: 2026-06-01DOI: 10.1093/jscdis/yoag020.001

  2. Secretory phospholipase A2 (sPLA2) during vaso-occlusive pain episodes (VOE) and acute chest syndrome (ACS) in sickle cell disease (SCD): results from a prospective multi-center randomized controlled trial (RCT)

    Noor Alzraikat, Rawan Korman, Fahd Ahmad, Gladstone Airewele, Bolanle Akinsola, Nitya Bakshi, David C Brousseau, Kathleen Brown, Andrew D Campbell, T Charles Casper, Todd P Chang, Corrie E Chumpitazi, Daniel Cohen, Keli D Coleman, Andrea T Cruz, Carlton Dampier, Christopher Denton, Angela Ellison, Melanie E Fields, Hailey Jensen, Elizabeth S Klings, Dunia Hatabah, Sara Leibovich, Derek Meyer, Seth Otto, Chris A Rees, Allison Remiker, Nidhi V Singh, Alexis A Thompson, Elliott Vichinsky, Anthony Villella, Bridget Wynn, Claudia R Morris

    Published: 2026-06-01DOI: 10.1093/jscdis/yoag020.010

  3. Using Electronic-Medical Records to Facilitate Transition From Pediatric to Adult Hematology for Sickle Cell Disease

    Venée N Tubman, Abdullah Kutlar, Albert C Hergenroeder, Alexis A Thompson, Constance M Wiemann, Oluwaseun Olaiya, Kenneth A Rivlin, Mary E Sehl, Modupe Idowu, Titilope Fasipe, Batha Tariq, Amanda Gregg, Bianca Bernal, Candice Deler, Duc T Nguyen, Diane Wilkins, Jemimah O Frempong, Kenneth Nobleza, Melanie M Aviles, Noe Gonzalez, Osarenkhoe Iyamu, Siera Gollan, Smirthy Ganesan, Raymona H Lawrence

    Published: 2026-06-01DOI: 10.1093/jscdis/yoag020.025

Volumes

2026 · 1342025 · 832024 · 67

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.